898
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Resolution of pulmonary artery thrombosis in patients with moderate COVID-19 disease

, ORCID Icon, , , , , , & show all
Pages 470-472 | Received 01 Dec 2020, Accepted 21 Apr 2021, Published online: 21 Jun 2021

References

  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
  • Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID‐19. J Thromb Haemost. 2020;18(7):1559–1561.
  • Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Ematological findings and complications of COVID-19. Am J Ematol. 2020;95(7):834–847. 10.1002/ajh.25829
  • Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Resp Med. 2020;8(4):420–422
  • Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099. DOI:10.1111/jth.14817
  • Glas GJ, Van Der Sluijs KF, Schultz MJ, et al. Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome. J Thromb Haemost. 2013;11:17–25.
  • Dolhnikoff M, Duarte-Neto AN, De Almeida Monteiro RA, et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. 2020. DOI:10.1111/jth.14844.
  • Thachil J, Cushman M, Srivastava A. A proposal for staging COVID-19 coagulopathy. Res Pract Thromb Haemost. 2020;4:731–736.
  • Cattaneo M, Bertinato EM, Birocchi S, et al. Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified? Thromb Haemost. 2020. [in press]. DOI:10.1055/s-0040-1712097Fogarty
  • Maatman TK, Jalali FC, Douglas A, et al. Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019. Crit Care Med. 2020;48(9):e783–e790.
  • Graziani A, Domenicali M, Zanframundo G, et al. Pulmonary artery thrombosis in patients with COVID 19. Pulmonol. 2020. DOI:10.1016/j.pulmoe.2020.07.013
  • Nijkeuter M, Hovens MC, Davidson BL, et al. Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. Chest. 2006;129(1):192–197.
  • Aghayev A, Furlan A, Patil A, et al. The rate of resolution of clot burden measured by pulmonary CT angiography in patients with acute pulmonary embolism. AJR Am J Roentgenol. 2013;200(4):791–797.
  • Den Exter PL, Van Es J, Ljm K, et al. Prometheus follow-up investigators. Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism. Thromb Haemost. 2015;114(1):26–34. .
  • Choi KJ, Cha SI, Shin KM, et al. Factors determining clot resolution in patients with acute pulmonary embolism. Blood Coagul Fibrinolysis. 2016;27(3):294–300.